Skip to content

Clinical study of cardiopulmonary rehabilitation program of integrated traditional Chinese and western medicine in primary and secondary prevention of coronary heart disease

Clinical study of cardiopulmonary rehabilitation program of integrated traditional Chinese and western medicine in primary and secondary prevention of coronary heart disease

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046182
Enrollment
Unknown
Registered
2021-05-08
Start date
2019-08-01
Completion date
Unknown
Last updated
2021-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease/metabolic syndrome

Interventions

Sponsors

Guang'anmen Hospital of China Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Metabolic syndrome (MS) group: 1) Aged 18 to 65 years; 2) Diagnosed as MS and do not meet the diagnostic criteria for coronary heart disease; 2. Coronary heart disease angina pectoris (SA) group: 1) Aged 18 to 65 years; 2) Diagnosed as SA.

Exclusion criteria

Exclusion criteria: 1. People with mental disorders or movement disorders; 2. Complicated with severe cardiac, cerebral, renal and vascular diseases and instability; 3. Patients with acute coronary syndrome, non-sinus rhythm, atrial fibrillation, atrial flutter, various types of conduction block and ventricular rhythm, etc., and patients with severe cardiopulmonary dysfunction were shown by cardiopulmonary exercise test; 4. Various infections, acute metabolic disorders, diabetic foot and other serious complications of diabetes; 5. Systolic blood pressure >= 200mmHg and/or diastolic blood pressure >= 100mmHg; 6. Pregnant or lactating woman; 7. A past or current history of cancer or other fatal disease that affects short-term survival; 8. Serious bone and joint disease, can not cooperate with the experimenter.

Design outcomes

Primary

MeasureTime frame
6 min walking test;The Seattle Angina Scale;Quality of Life;Seattle Angina Scale score;SAS, SDS score;

Secondary

MeasureTime frame
Blood lipids;Uric acid;HCY(homocysteine);C-reactive protein, CRP;

Countries

China

Contacts

Public ContactWang Shihan

Guang'anmen Hospital of China Academy of Traditional Chinese Medicine

Wangshihan91@126.com+86 13910838435

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026